Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

PX855 Citations (3)

Originally described in: A split-Cas9 architecture for inducible genome editing and transcription modulation.
Zetsche B, Volz SE, Zhang F Nat Biotechnol. 2015 Feb 2. doi: 10.1038/nbt.3149.
PubMed Journal

Articles Citing PX855

Engineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors. Baeumler TA, Ahmed AA, Fulga TA. Cell Rep. 2017 Sep 12;20(11):2639-2653. doi: 10.1016/j.celrep.2017.08.044. PubMed

Associated Plasmids

Multimode drug inducible CRISPR/Cas9 devices for transcriptional activation and genome editing. Lu J, Zhao C, Zhao Y, Zhang J, Zhang Y, Chen L, Han Q, Ying Y, Peng S, Ai R, Wang Y. Nucleic Acids Res. 2018 Mar 16;46(5):e25. doi: 10.1093/nar/gkx1222. PubMed

Associated Plasmids

Spatial and temporal control of gene manipulation in Drosophila via drug-activated Cas9 nucleases. Huynh N, Wang S, King-Jones K. Insect Biochem Mol Biol. 2020 May;120:103336. doi: 10.1016/j.ibmb.2020.103336. Epub 2020 Feb 24. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.